Country: United States
Language: English
Source: NLM (National Library of Medicine)
PYRIMETHAMINE (UNII: Z3614QOX8W) (PYRIMETHAMINE - UNII:Z3614QOX8W)
Aurobindo Pharma Limited
ORAL
PRESCRIPTION DRUG
Treatment of Toxoplasmosis: Pyrimethamine tablets are indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. Use of pyrimethamine tablets are contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. Use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.
Pyrimethamine Tablets USP, 25 mg are white to off-white round shaped, biconvex, uncoated tablet, debossed with ‘L’ ‘25’ on one side and break line on other side. They are supplied as follows: Bottles of 30 NDC 59651-590-30 Bottles of 100 NDC 59651-590-01 Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature] in a dry place and protect from light.
Abbreviated New Drug Application
PYRIMETHAMINE - PYRIMETHAMINE TABLET AUROBINDO PHARMA LIMITED ---------- PYRIMETHAMINE TABLETS, USP RX ONLY PRESCRIBING INFORMATION DESCRIPTION Pyrimethamine is an antiparasitic compound available in tablet form for oral administration. Each scored tablet contains 25 mg pyrimethamine USP and the inactive ingredients colloidal silicon dioxide, lactose monohydrate, magnesium stearate and pregelatinized starch (corn). Pyrimethamine USP, known chemically as 5-(4- chlorophenyl)-6-ethyl-2, 4- pyrimidinediamine, has the following structural formula: CLINICAL PHARMACOLOGY Pyrimethamine is well absorbed with peak levels occurring between 2 to 6 hours following administration. It is eliminated slowly and has a plasma half-life of approximately 96 hours. Pyrimethamine is 87% bound to human plasma proteins. MICROBIOLOGY: Pyrimethamine is a folic acid antagonist and the rationale for its therapeutic action is based on the differential requirement between host and parasite for nucleic acid precursors involved in growth. This activity is highly selective against _Toxoplasma gondii._ The action of pyrimethamine against _Toxoplasma gondii _is greatly enhanced when used in conjunction with sulfonamides. This was demonstrated by Eyles and Coleman in the treatment of experimental toxoplasmosis in the mouse. Jacobs et al demonstrated that combination of the 2 drugs effectively prevented the development of severe uveitis in most rabbits following the inoculation of the anterior chamber of the eye with toxoplasma. INDICATIONS AND USAGE TREATMENT OF TOXOPLASMOSIS: Pyrimethamine tablets are indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. 1 2 CONTRAINDICATIONS Use of pyrimethamine tablets are contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. Use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency. WARNINGS The dosage of pyrimethamine req Read the complete document